Receptors, Transforming Growth Factor beta
"Receptors, Transforming Growth Factor beta" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell-surface proteins that bind transforming growth factor beta and trigger changes influencing the behavior of cells. Two types of transforming growth factor receptors have been recognized. They differ in affinity for different members of the transforming growth factor beta family and in cellular mechanisms of action.
|Receptors, Transforming Growth Factor beta
- Receptors, Transforming Growth Factor beta
- Transforming Growth Factor beta Receptors
- Receptors, TGF-beta
- Receptors, TGF beta
- TGF-beta Receptor
- Receptor, TGF-beta
- TGF beta Receptor
- TGF-beta Receptors
- TGF beta Receptors
- Transforming Growth Factor beta Receptor
Below are MeSH descriptors whose meaning is more general than "Receptors, Transforming Growth Factor beta".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Transforming Growth Factor beta".
This graph shows the total number of publications written about "Receptors, Transforming Growth Factor beta" by people in this website by year, and whether "Receptors, Transforming Growth Factor beta" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Transforming Growth Factor beta" by people in Profiles.
Cellular and extracellular matrix of bone, with principles of synthesis and dependency of mineral deposition on cell membrane transport. Am J Physiol Cell Physiol. 2020 01 01; 318(1):C111-C124.
Anti-fibrotic effects of tannic acid through regulation of a sustained TGF-beta receptor signaling. Respir Res. 2019 Jul 29; 20(1):168.
TGF? receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer. Cancer Chemother Pharmacol. 2019 05; 83(5):975-991.
Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGF? enhance the efficacy of cancer immunotherapy. Nat Commun. 2018 02 21; 9(1):741.
Genetic modifiers of muscular dystrophy act on sarcolemmal resealing and recovery from injury. PLoS Genet. 2017 Oct; 13(10):e1007070.
A new developmental mechanism for the separation of the mammalian middle ear ossicles from the jaw. Proc Biol Sci. 2017 02 08; 284(1848).
Integrated genomic and molecular characterization of cervical cancer. Nature. 2017 03 16; 543(7645):378-384.
Downregulation of TGF-? Receptor-2 Expression and Signaling through Inhibition of Na/K-ATPase. PLoS One. 2016; 11(12):e0168363.
TGF-? receptor 1 inhibition prevents stenosis of tissue-engineered vascular grafts by reducing host mononuclear phagocyte activation. FASEB J. 2016 07; 30(7):2627-36.
Common pathways regulate Type III TGF? receptor-dependent cell invasion in epicardial and endocardial cells. Cell Signal. 2016 Jun; 28(6):688-98.